Department of Anesthesiology and Critical Care Medicine, Baltimore, MD, United States of America.
Department of Psychiatry & Behavioral Sciences, Baltimore, MD, United States of America.
PLoS One. 2021 Dec 8;16(12):e0256973. doi: 10.1371/journal.pone.0256973. eCollection 2021.
We recently identified a nuclear-encoded miRNA (miR-181c) in cardiomyocytes that can translocate into mitochondria to regulate mitochondrial gene mt-COX1 and influence obesity-induced cardiac dysfunction through the mitochondrial pathway. Because liver plays a pivotal role during obesity, we hypothesized that miR-181c might contribute to the pathophysiological complications associated with obesity. Therefore, we used miR-181c/d-/- mice to study the role of miR-181c in hepatocyte lipogenesis during diet-induced obesity. The mice were fed a high-fat (HF) diet for 26 weeks, during which indirect calorimetric measurements were made. Quantitative PCR (qPCR) was used to examine the expression of genes involved in lipid synthesis. We found that miR-181c/d-/- mice were not protected against all metabolic consequences of HF exposure. After 26 weeks, the miR-181c/d-/- mice had a significantly higher body fat percentage than did wild-type (WT) mice. Glucose tolerance tests showed hyperinsulinemia and hyperglycemia, indicative of insulin insensitivity in the miR-181c/d-/- mice. miR-181c/d-/- mice fed the HF diet had higher serum and liver triglyceride levels than did WT mice fed the same diet. qPCR data showed that several genes regulated by isocitrate dehydrogenase 1 (IDH1) were more upregulated in miR-181c/d-/- liver than in WT liver. Furthermore, miR-181c delivered in vivo via adeno-associated virus attenuated the lipogenesis by downregulating these same lipid synthesis genes in the liver. In hepatocytes, miR-181c regulates lipid biosynthesis by targeting IDH1. Taken together, the data indicate that overexpression of miR-181c can be beneficial for various lipid metabolism disorders.
我们最近在心肌细胞中鉴定出一种核编码的 miRNA(miR-181c),它可以转移到线粒体中,通过线粒体途径调节线粒体基因 mt-COX1,并影响肥胖引起的心脏功能障碍。因为肝脏在肥胖过程中起着关键作用,我们假设 miR-181c 可能有助于与肥胖相关的病理生理并发症。因此,我们使用 miR-181c/d-/- 小鼠研究 miR-181c 在饮食诱导肥胖期间肝细胞脂肪生成中的作用。这些小鼠喂食高脂肪(HF)饮食 26 周,在此期间进行间接热量测量。定量 PCR(qPCR)用于检测参与脂质合成的基因的表达。我们发现,miR-181c/d-/- 小鼠不能免受 HF 暴露的所有代谢后果的影响。26 周后,miR-181c/d-/- 小鼠的体脂肪百分比明显高于野生型(WT)小鼠。葡萄糖耐量试验显示高胰岛素血症和高血糖,表明 miR-181c/d-/- 小鼠胰岛素不敏感。喂食 HF 饮食的 miR-181c/d-/- 小鼠的血清和肝脏甘油三酯水平高于喂食相同饮食的 WT 小鼠。qPCR 数据显示,几种受异柠檬酸脱氢酶 1(IDH1)调节的基因在 miR-181c/d-/- 肝脏中的表达上调更为明显WT 肝脏。此外,通过腺相关病毒体内递送的 miR-181c 通过下调这些相同的肝脏脂质合成基因来减弱脂肪生成。在肝细胞中,miR-181c 通过靶向 IDH1 调节脂质生物合成。总之,这些数据表明 miR-181c 的过表达可能有益于各种脂质代谢紊乱。